From: Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma
Group | Dosage (μg/mL) | BxPC-3 | Panc-1 | ||||
---|---|---|---|---|---|---|---|
G0/G1 | S | G2/M | G0/G1 | S | G2/M | ||
Control | – | 75.8 ± 1.9 | 18.6 ± 0.8 | 5.6 ± 0.05 | 86.1 ± 1.2 | 6.3 ± 0.07 | 7.6 ± 0.04 |
Elemene | 15 | 61.2 ± 1.3* | 34.6 ± 0.7* | 4.2 ± 0.03* | 78.3 ± 0.9* | 15.2 ± 0.6* | 6.5 ± 0.03* |
30 | 47.7 ± 0.9** | 49.1 ± 0.6** | 3.2 ± 0.02** | 60.1 ± 0.7** | 34.8 ± 0.9** | 5.1 ± 0.02** | |
60 | 30.6 ± 0.5** | 66.7 ± 0.8** | 2.7 ± 0.09** | 46.3 ± 0.8** | 50.1 ± 1.1** | 3.6 ± 0.04** |